ACE and familial dilated cardiomyopathy: Here, an angiotensin-converting enzyme inhibitor (ACE inhibitor) is administered to family members of DCM patients that carry a (presumed) pathogenic mutation, to see if this can delay or prevent the occurrence of DCM [19].